Neogen (NASDAQ:NEOG) Hits New 12-Month Low at $15.82

Neogen Co. (NASDAQ:NEOGGet Rating)’s stock price reached a new 52-week low during trading on Monday . The stock traded as low as $15.82 and last traded at $16.11, with a volume of 345218 shares traded. The stock had previously closed at $16.17.

Analyst Ratings Changes

Separately, Piper Sandler dropped their target price on shares of Neogen from $26.00 to $20.00 and set a “neutral” rating for the company in a research report on Tuesday, August 30th.

Neogen Stock Performance

The company has a market capitalization of $1.65 billion, a PE ratio of 33.98 and a beta of 0.61. The business’s 50-day moving average is $20.50 and its 200-day moving average is $25.39.

Insider Activity at Neogen

In other Neogen news, Director James P. Tobin purchased 2,000 shares of the stock in a transaction that occurred on Wednesday, July 27th. The stock was bought at an average cost of $22.98 per share, with a total value of $45,960.00. Following the transaction, the director now directly owns 14,000 shares in the company, valued at approximately $321,720. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, Director Ronald D. Green bought 1,500 shares of the firm’s stock in a transaction on Tuesday, August 2nd. The stock was acquired at an average cost of $22.50 per share, with a total value of $33,750.00. Following the completion of the acquisition, the director now owns 10,694 shares of the company’s stock, valued at $240,615. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director James P. Tobin bought 2,000 shares of the firm’s stock in a transaction on Wednesday, July 27th. The stock was purchased at an average cost of $22.98 per share, with a total value of $45,960.00. Following the completion of the acquisition, the director now directly owns 14,000 shares of the company’s stock, valued at approximately $321,720. The disclosure for this purchase can be found here. Insiders acquired a total of 22,100 shares of company stock valued at $507,448 in the last three months. Company insiders own 0.73% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Stephens Inc. AR raised its holdings in Neogen by 3.9% in the fourth quarter. Stephens Inc. AR now owns 10,685 shares of the company’s stock worth $485,000 after buying an additional 401 shares during the last quarter. Patriot Financial Group Insurance Agency LLC grew its stake in shares of Neogen by 87.5% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 913 shares of the company’s stock worth $28,000 after acquiring an additional 426 shares during the period. Crossmark Global Holdings Inc. grew its stake in shares of Neogen by 4.4% in the first quarter. Crossmark Global Holdings Inc. now owns 10,284 shares of the company’s stock worth $317,000 after acquiring an additional 430 shares during the period. Raymond James Trust N.A. grew its stake in shares of Neogen by 6.7% in the first quarter. Raymond James Trust N.A. now owns 6,981 shares of the company’s stock worth $215,000 after acquiring an additional 441 shares during the period. Finally, Louisiana State Employees Retirement System grew its stake in shares of Neogen by 2.2% in the first quarter. Louisiana State Employees Retirement System now owns 28,200 shares of the company’s stock worth $833,000 after acquiring an additional 600 shares during the period. 97.86% of the stock is owned by hedge funds and other institutional investors.

Neogen Company Profile

(Get Rating)

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells.

Featured Articles

Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.